Latest article
Progressive €250,000 Parenteral Diet Analysis Grant Awarded by Fresenius Kabi
This year's winner is a professor Stefan Schaller MD of the Charité - University Medicine Berlin, Germany, for his proposal entitled "Improved muscle metabolism...
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...